Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DE-089 vs Sodium Hyaluronate in Dry Eye
NCT01240382Phase 3Completed
- Sponsor
- Santen Pharmaceutical
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diquafosol in dry eye syndrome (DED) (2 arms), sponsored by Santen Pharmaceutical. Primary endpoints: Mean Change in Fluorescein Staining Score From Baseline at 4 weeks and Mean Change in Rose Bengal Staining Score From Baseline at 4 weeks. Status: completed.
02
Drugs
diquafosol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT01240382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01240382.